Neuralink, Elon Musk’s brain implant company, has received approval from the FDA to begin testing its device in humans. The company aims to merge humans with machines to treat various medical conditions and enhance existing abilities. Neuralink’s device, called the “Link,” is a brain chip that can directly interface with the human brain. It uses tiny electrodes implanted in the brain tissue to enable communication between neurons, allowing users to control computers and devices with their thoughts. While other companies are also working on brain implants, Neuralink receives more attention due to its funding and connection to Musk. The company’s vision goes beyond restoration and aims to enhance human abilities, raising ethical concerns. Better regulation and discussion are needed to address these issues and protect mental privacy. Bradley Greger, an associate professor of bioengineering in the School of Biological and Health Systems Engineering, says that beginning human trials is a significant milestone in the process and that there is a lot of space in the burgeoning industry for multiple companies to make their mark.